perioperative management of glp-1 agonists receptor like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become incredibly common in diabetes and weight-management care, and they're now showing up more and more in the setting. These Evaluation of safety of preoperative

At the cellular level, GLP-1 receptor activation appears to reduce the production of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-), interleukin-6 (IL-6), and interleukin-1 beta (IL-1)

Effect of semaglutide 2.4 mg once weekly on 10-year type 2 diabetes risk in adults with overweight or obesity

In addition, few studies currently support the use of GLP-1RAs in patients with HFrEF

Currently, about 18,000 members use these drugs for weight loss

Retatrutide Weight Loss Results Trial Data and FDA Status: What It Means for Patients The phrase Retatrutide weight loss results trial data and FDA status should remind patients to look at both hope and caution